These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 2852930)

  • 1. Tissue angiotensin-converting enzyme blockade by MC-838 (altiopril calcium) infused intravenously to miniature pigs: comparison with captopril.
    Sakai K; Shiraki Y; Akima M; Imagawa J; Hinohara Y; Koga T; Ichihara T; Tohira Y
    Arch Int Pharmacodyn Ther; 1988; 294():228-40. PubMed ID: 2852930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril.
    Aono J; Koga T; Yamazaki T; Shiraki Y; Sakai K
    Arch Int Pharmacodyn Ther; 1988; 292():203-22. PubMed ID: 3293542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative cardiovascular effects of a novel angiotensin converting enzyme inhibitor altiopril calcium (MC-838) and captopril in spontaneously hypertensive rats.
    Akima M; Shiraki Y; Sakai K
    Arch Int Pharmacodyn Ther; 1988; 292():223-36. PubMed ID: 3293543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cadmium and captopril on serum angiotensin converting enzyme activity in rats.
    Puri VN
    Indian Heart J; 1997; 49(3):297-9. PubMed ID: 9291654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between lung and plasma angiotensin converting enzyme and the hypotensive effect of captopril in conscious rabbits.
    Chen X; Pitt BR; Moalli R; Gillis CN
    J Pharmacol Exp Ther; 1984 Jun; 229(3):649-53. PubMed ID: 6327968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of angiotensin-converting enzyme two-week inhibition on renal angiotensin II receptors and renal vascular reactivity in SHR.
    Haddad G; Garcia R
    J Mol Cell Cardiol; 1997 Feb; 29(2):813-22. PubMed ID: 9140837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MC-838 (altiopril calcium): a novel orally active angiotensin converting enzyme inhibitor.
    Sakai K; Aono J; Shiraki Y; Hinohara Y; Akamatsu A; Tanaka S; Kuromaru K
    Tohoku J Exp Med; 1987 Aug; 152(4):363-74. PubMed ID: 3660405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of the tissue angiotensin converting enzyme to the antihypertensive effect of altiopril calcium (MC-838) in spontaneously hypertensive rats.
    Kamei K; Shiraki Y; Koga T; Sakai K
    J Pharm Pharmacol; 1989 Apr; 41(4):279-80. PubMed ID: 2568474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological evaluation in conscious dogs of factors involved in the renal vasodilator effect of captopril.
    Wong PC; Zimmerman BG; Kraft E; Kounenis G; Friedman P
    J Pharmacol Exp Ther; 1981 Dec; 219(3):646-50. PubMed ID: 7028950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responses of renal, coronary and vertebral vasculatures to MC-838 and captopril in anesthetized dogs.
    Noguchi K; Kato T; Sunagawa R; Sakanashi M
    Pharmacology; 1987; 34(1):48-56. PubMed ID: 3033709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of renal hemodynamic effect of ramiprilat to captopril; possible role of kinins.
    Chen K; Zimmerman BG
    J Pharmacol Exp Ther; 1994 Aug; 270(2):491-7. PubMed ID: 8071842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of the renal responses to bradykinin by inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in anesthetized dogs.
    Seymour AA; Sheldon JH; Smith PL; Asaad M; Rogers WL
    J Pharmacol Exp Ther; 1994 Apr; 269(1):263-70. PubMed ID: 8169834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal targeting of captopril using captopril-lysozyme conjugate enhances its antiproteinuric effect in adriamycin-induced nephrosis.
    Windt WA; Prakash J; Kok RJ; Moolenaar F; Kluppel CA; de Zeeuw D; van Dokkum RP; Henning RH
    J Renin Angiotensin Aldosterone Syst; 2004 Dec; 5(4):197-202. PubMed ID: 15803438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.
    Bralet J; Marie C; Mossiat C; Lecomte JM; Gros C; Schwartz JC
    J Pharmacol Exp Ther; 1994 Jul; 270(1):8-14. PubMed ID: 8035346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of chronic captopril treatment on circulating and tissue renin-angiotensin system in SHR rats.
    Hu WY; Chen DG; Chen SC; Jin XQ; Wang HJ
    Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):507-12. PubMed ID: 9863143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between inhibition of renal angiotensin II production and hemodynamic effect of captopril in anesthetized rabbit.
    Li T; Zimmerman BG
    J Hypertens; 1992 Aug; 10(8):795-805. PubMed ID: 1325512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of angiotensin converting enzyme from sheep tissues by captopril, lisinopril and enalapril.
    Udupa EG; Rao NM
    Indian J Biochem Biophys; 1997 Dec; 34(6):524-8. PubMed ID: 9594434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of captopril (SQ 14225) on blood pressure, plasma renin activity and angiotensin I converting enzyme activity.
    Larochelle P; Genest J; Kuchel O; Boucher R; Gutkowska Y; McKinstry D
    Can Med Assoc J; 1979 Aug; 121(3):309-16. PubMed ID: 223756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of idrapril: a new class of angiotensin converting enzyme inhibitors.
    Subissi A; Criscuoli M; Sardelli G; Guelfi M; Giachetti A
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):139-46. PubMed ID: 1383623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive activity of captopril (SQ 14,225), an orally active inhibitor of angiotensin converting enzyme in conscious two-kidney perinephritic hypertensive dogs.
    Vollmer RR; Boccagno JA; Steinbacher TE; Horovitz ZP; Murthy VS
    J Pharmacol Exp Ther; 1981 Feb; 216(2):225-31. PubMed ID: 6257882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.